Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Exercise or conversion Director acquired 12,500 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award Director acquired 10,200 shares (grant or award)
  8. 4 Grant or award Director acquired 10,200 shares (grant or award)
  9. 4 Grant or award Director acquired 10,200 shares (grant or award)
  10. 4 Open-market sale Director sold 3,665 shares at $17.78 ($65,164)
  11. 4 Open-market sale Director sold 4,600 shares at $17.94 ($82,524)
  12. 4 Open-market sale Director sold 3,665 shares at $17.78 ($65,164)
  13. 4 Exercise or conversion Director acquired 40,000 shares (option exercise)
  14. 4 Open-market sale Director sold 18,279 shares at an average $16.01 ($292,670)
  15. 4 Exercise or conversion Director acquired 45,000 shares (option exercise)
  16. 4 Gift Director gave 6,300 shares (gift)
  17. 4 Open-market sale Chief R&D Officer sold 7,662 shares at $13.83 ($105,965)
  18. 4 Open-market sale SVP & General Counsel sold 1,910 shares at $13.83 ($26,415)
  19. 4 Open-market sale President & CEO sold 11,515 shares at $13.83 ($159,252)
  20. 4 Open-market sale SVP & Chief Accounting Officer sold 13,339 shares at $13.83 ($184,478)

Page 8 of 49 · 968 filings